Literature DB >> 35198041

A review of the therapeutic management of Crohn's disease.

Aditi Kumar1, Alexander Cole2, Jonathan Segal3, Philip Smith4, Jimmy K Limdi5.   

Abstract

Crohn's disease is a chronic inflammatory, relapsing-remitting, and progressive gastrointestinal disorder with an often-negative impact on the physical, emotional, and psychological well-being. Over the past two decades, the medical compendium for the treatment of Crohn's disease has increased significantly, enabling treatment beyond symptoms. Indeed, early and timely use of effective medical therapy has been reflected by improved outcomes with reduction in surgery and ability to achieve clinical and endoscopic remission, reduce corticosteroid dependance, and prevent long-term complications in more patients. In this review, we discuss the key milestones in the medical management of Crohn's disease.
© The Author(s), 2022.

Entities:  

Keywords:  Crohn’s disease; inflammatory bowel disease; ulcerative colitis

Year:  2022        PMID: 35198041      PMCID: PMC8859667          DOI: 10.1177/17562848221078456

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


  116 in total

1.  The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study.

Authors:  W A Faubion; E V Loftus; W S Harmsen; A R Zinsmeister; W J Sandborn
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

Review 2.  NUDT15: A bench to bedside success story.

Authors:  Ann M Moyer
Journal:  Clin Biochem       Date:  2021-03-04       Impact factor: 3.281

3.  Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.

Authors:  P Rutgeerts; M Hiele; K Geboes; M Peeters; F Penninckx; R Aerts; R Kerremans
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

4.  Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

Authors:  R Modigliani; J Y Mary; J F Simon; A Cortot; J C Soule; J P Gendre; E Rene
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

5.  Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease.

Authors:  Paul Rutgeerts; Christopher Gasink; Daphne Chan; Yinghua Lang; Paul Pollack; Jean-Frederic Colombel; Douglas C Wolf; Douglas Jacobstein; Jewel Johanns; Philippe Szapary; Omoniyi J Adedokun; Brian G Feagan; William J Sandborn
Journal:  Gastroenterology       Date:  2018-08-29       Impact factor: 22.682

Review 6.  The role of vedolizumab in patients with moderate-to-severe Crohn's disease and ulcerative colitis.

Authors:  Neal Shahidi; Brian Bressler; Remo Panaccione
Journal:  Therap Adv Gastroenterol       Date:  2016-03-07       Impact factor: 4.409

7.  European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.

Authors:  H Malchow; K Ewe; J W Brandes; H Goebell; H Ehms; H Sommer; H Jesdinsky
Journal:  Gastroenterology       Date:  1984-02       Impact factor: 22.682

8.  Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy.

Authors:  Geert D'Haens; Walter Reinisch; Jean-Frederic Colombel; Julian Panes; Subrata Ghosh; Cosimo Prantera; Stefan Lindgren; Daniel W Hommes; Zhiping Huang; Judith Boice; Susan Huyck; Freddy Cornillie
Journal:  J Crohns Colitis       Date:  2017-06-01       Impact factor: 9.071

9.  Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry.

Authors:  Gary R Lichtenstein; Brian G Feagan; Russell D Cohen; Bruce A Salzberg; Robert H Diamond; Samiyeh Price; Wayne Langholff; Anil Londhe; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2012-08-14       Impact factor: 10.864

10.  Budesonide for the Induction and Maintenance of Remission in Crohn's Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration.

Authors:  M Ellen Kuenzig; Ali Rezaie; Gilaad G Kaplan; Anthony R Otley; A Hillary Steinhart; Anne Marie Griffiths; Eric I Benchimol; Cynthia H Seow
Journal:  J Can Assoc Gastroenterol       Date:  2018-05-24
View more
  1 in total

1.  Fueling the fire in the gut.

Authors:  Chia-Hao Lin; Li-Fan Lu
Journal:  J Exp Med       Date:  2022-05-27       Impact factor: 17.579

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.